Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results

Go back to Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results
(NASDAQ: KRYS) Delayed: 358.94 -0.82 (0.23%)
Previous Close $359.76    52 Week High
Open $357.61    52 Week Low
Day High $362.48    P/E N/A 
Day Low $356.44    EPS
Volume 13,969